Microcatheters Market Research Report—Global Forecast till 2027

Microcatheters Market: Information by Design (Single and Double Lumen), Product (Aspiration, Delivery, Diagnostic, Steerable), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology, Urology), End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027

ID: MRFR/HC/9129-HCR | June 2021 | Region: Global | 120 pages

Microcatheters Market Forecast


The Microcatheters Market is expected to cross ~USD 2,412.0 million by 2027 at a CAGR of ~4.1% during the forecast period of 2021 to 2027.


Market Overview:


Microcatheters are the thin wall, small diameter catheters used in minimally invasive procedures, ideal for navigating the vast network of tiny veins found within the human body. These procedures are primarily employed in neurovascular and cardiovascular applications. They are most commonly used in selective applications where the anatomy would not be accessible via a standard catheter. Factors such as the rise in the prevalence of chronic diseases, includingneurovascular and cardiovascular disorders, increased adoption of minimally invasive procedures, and development of new diagnostic centers and hospitals in emerging economies are the key drivers ofthe global microcatheters market. There is an increasing preference for minimally invasive surgeries due to lower risk than traditional surgeries because they use smaller surgical incisions. Thus, all the above-mentioned factors are contributing to the growth of the microcatheter market.


In January 2021, Baylis Medical (Canada) launched the first clinical case in Europe of the JLL 2-French electrophysiology microcatheter. The JLL electrophysiology catheter was launched in partnership with Japan Lifeline Ltd (Japan), a leading Japanese cardiovascular device developer and manufacturer.Its family involves a 6F guiding catheter and a 2F microcatheter, which can be combined to allow deeper Coronary Sinus (CS) mapping. In August 2020, Cerus Endovascular Inc. (US) announced that it received FDA approval for its first microcatheter. Its 021 microcatheter is available in three different distal configurations.


COVID-19 Analysis


The COVID-19 pandemic has significantly impacted the number of surgical procedures performed.It has also led to workforce and staffing issues, changes in perioperative practices, and viral transmission risk intraoperatively. Many countries around the world made the necessary decisions to cancel all non-emergency surgical procedures to free up personnel and resources for COVID-19 patients. It is estimated that during the initial wave of COVID-19, at least 28 million elective operations were canceled. This significantly decreased the demand for microcatheters used for several surgical procedures.


The COVID-19 pandemic also had an impact on the operations of microcatheter manufacturers. Lockdowns had a negative impact on the supply chain and manufacturing facilities.This increased downward pressure on microcatheter production and demand.It also affected the import and export of medical devices.


Market Dynamics


Drivers



  • Rise in the prevalence of chronic diseases such as neurovascular and cardiovascular disorders




    • Factors such as unhealthy diet, physical inactivity, tobacco use, and consumption of alcohol lead to heart diseases. It is also estimated that prevalent cases of total cardiovascular disease nearly doubled from 271 million in 1990 to 523 million in the year 2019.

    • Neurovascular disease refers to all disorders in which an area of the brain is temporarily or permanently affected by bleeding or restricted blood flow due to abnormality found in the blood vessel of the brain or spinal cord that supplies fresh oxygenated blood. Neurovascular catheters are used to treat numerous diseases, such as brain aneurysms, embolic stroke, arteriovenous malformations, and other disorders. Microcatheters are used during complex cardiovascular procedures to provide support and safe guidewire exchange.



Increasing adoption of minimally invasive surgery



  • The demand for minimally invasive surgery is increasing due to its advantages over traditional open surgeries that include smaller and fewer scars, less pain, shorter hospital stays and recovery periods, reduction in costs, and overall better outcomes.One of the most common tools used in minimally invasive surgery is a catheter. This is creating demand for microcatheters worldwide.


Market Opportunities



  • Technological advancements in the medical science


    • Technological advancements in medical science aremaking medical practice easier for physicians, more effective for the patients and cheaper for the entire healthcare system. These advancements provide patients with precise treatments that are less costly, less invasive and less complicated due to more advanced tools

    • The emergence of technological advancements in the design of catheters in the past decaderesulted intheir long-term efficiency, decreased infection rates, and reduced catheter malfunction. These catheters have undergone numerous improvements because of the rise in the R&D in catheters.



Increasing government funding for strengthening healthcare infrastructure



  • The governments of developed and developing regions are funding public health care to deliver high-quality healthcare to its people. Improved performance in controlling emerging and re-emerging diseases in various regions depends on the quality, equity, and efficiency of the health system in these regions.

  • The current COVID-19 pandemic creates awareness about strengthening the healthcare system among various governments worldwide. This is increasing investments by governmentsin the public healthcare system.


Market Restraints



  • Risks associated with microcatheter use


    • Microcatheters are generally safe for use, but some risks are associated with theiruse. Complications such as bleeding andthe risk of infections are associated with microcatheter applications in surgery. The material used in the microcatheter may also cause allergic reactions.

    • These risks are hampering the global microcatheter market growth. The manufacturers are now focusing on manufacturing the most advanced microcatheters that can cause less risk during use.



Technology Analysis



  • A microcatheter is a small diameter catheter used to treat vascular diseases. Themanufacturers are launching new advanced products in the market. New microcatheters have been introduced in clinical practice aiming to improve deliverability and resistance to deformation. In July 2020, Acist Medical Systems Inc. (US) launched AcistNavvus II Rapid Exchange Fractional Flow Reserve (FFR) microcatheter, the second-generation microcatheter for use with its AcistRXi Rapid Exchange FFR System. Fractional Flow Reserve (FFR) measurements provide an assessment of arterial lesion severity and inform intervention strategy in both diagnosis and treatment of coronary artery disease.The manufacturers are also designing microcatheters to lower the risk of non-target embolization.


Segment Overview

By Design


Single Lumen



  • The single lumen microcatheter has an elongated shaft having a distal and a proximal end. Its elongated shaft has an outer surface and an inner surface. The inner surface defines a single lumen extending from the proximal end to the distal end of the elongated shaft and fluidly connecting the proximal end to an opening at the distal end of the shaft.


Double Lumen



  • A double lumen microcatheter has many advantages, such as it does not compromise the side branch because guidewires coexist in the main branch and side branch. Dual lumen microcatheter has robust support and easy access to complex coronary vasculature. It has a dual lumen configuration that avoids the tangling of guidewires and improves guidewire manipulation.A robust proximal shaft maintains its stability and maneuverabilityand stronger penetration force compared to a conventional microcatheter.


By Product


Aspiration Microcatheter



  • Aspiration microcatheter are primarily employed using ADAPT (a direct aspiration first-pass technique). Aspiration microcatheter has a varying internal diameter (0.044–0.072 inch).It is a rapid exchange type of catheter that is commonly used to eliminate and provide a simple solution of Thrombus and Debris in the coronary or peripheral arteries.


Delivery Microcatheter



  • Delivery microcatheter has a high flow lumen, and its coil-wound construction enables confident large-volume coil delivery. These microcatheters help assist the delivery of diagnostic agents, such as contrast media, and therapeutic devices, such as occlusion coils, to the peripheral and neuro vasculature.


Diagnostic Microcatheter



  • A diagnostic microcatheter is used for diagnostic purposes. These microcatheters are being used to obtain a diagnostic cerebral angiogram in patients with anatomic challenges limiting catheterization. When an application requires an ultra-thin device for diagnosis, a diagnostic microcatheter is used.


Steerable Microcatheter



  • Steerable microcatheter facilitates faster vessel selection and fewer procedure times and may also result in less need to open multiple instrument packs during a case. These microcatheters are primarily designed to reach inaccessible areas for coronary and peripheral applications. It can be operated one-handed that articulates up to 180 degrees.

  • By Application


Cardiovascular



  • Microcatheters used for cardiovascular applications are generally run under 6 French (FR). The preference for microcatheters is high from interventional cardiologists during the complex coronary anatomy applications.


Neurovascular



  • The microcatheters are used for interventions in the brain and intracranial spaces to perform neurovascular surgeries. Microcatheters are used for various purposes, such as access to the neurovascular organs and delivery of embolic coils and thrombectomy devices. The number of neurovascular surgeries is increasing worldwide,which leads to high demand for microcatheters.


Peripheral Vascular



  • Microcatheters require precise components for angiography, aspiration, thrombectomy, and embolization in peripheral vascular applications. They are used for the treatment of numerous peripheral and vascular disorders.


Oncology



  • Microcatheters are used for numerous oncology procedural applications such as embolization, Transcatheter Embolization and Occlusion (TEO) and Uterine Fibroid Embolization (UFE).It helps to deliver chemotherapy treatments to cancerous tumors by navigating through smaller vessels to those localized sites.


Urology



  • Microcatheters are used for urological applications such as diagnostics and surgical interventions. They are used for urological applications and have multi-layer, large-lumen/low-profile extrusions and coil and wire coating capabilities.

  • By End User


Hospitals



  • The advancement in the hospital infrastructure across the globe is driving the microcatheters market. The development of new diagnostic centers and hospitals in the developing regions creates opportunities for the players involved in the microcatheter market.Hospitals are equipped with advanced equipment for the various procedure applications which are expected to influence market growth for microcatheters.


Ambulatory Surgical Centers:



  • The demand for ambulatory surgical centers is increasing owing to the immediate requirement for the treatment of cardiovascular and neurovascular diseases. These centers offer instant treatment to the patient. Such procedures are effective and economical.


Specialized Clinics:



  • The increasing number of specialized clinics for the treatment of various chronic diseases such as cardiovascular and neurovascular diseases. In developing regions, the number of specialized clinics is increasing, which is influencing the market growth.


Regional Analysis

North America

Increasing acceptance of technologically advanced products across the region is driving the North America microcathetersmarket



  • North America dominated themicrocathetermarket in 2020 due tothe availability and accessibility to technologically advanced products,increasing the number of percutaneous coronary intervention procedures, and rising favorable government initiatives. Also, there is an increasing prevalence of chronic disorders such as neurovascular, peripheral vascular, oncology, and cardiovascular in the region,which is also fueling the market growth. According to American Heart Association, 121.5 million adults in the US were living with cardiovascular disease, and 805,000 Americans were suffering from a heart attack by 2019.


Asia-Pacific
Increasing number of people suffering from chronic diseases is fueling the Asia-Pacificmicrocathetermarket



  • The Asia-Pacific is accounted to be the fastest-growing regional market for microcatheters due to the presence of a large patient pool, increasing prevalence & incidence of target diseases, and growing healthcare infrastructure in Asian countries. Moreover, other factors supporting the microcatheter market include increasing healthcare spending and favorable government initiatives for strengthening the healthcare infrastructure.


Competitive Landscape



  • Medtronic (Ireland) is one of the leading players in the microcatheter market, offering products for neurological and cardiovascular applications. The company offers peripheral embolization products, access and delivery products, AVM embolization products, and others. The company offers the rebar reinforced microcatheter. It is a single-lumen catheter with stainless steel construction, hydrophilic coating, and high kink resistance.

  • The market players are pursuing a variety of business strategies to increase their market share. The companies are launching innovative microcatheters with advanced techniques to gain a competitive advantage. They have made significant investments in R&D to bring new products to the market.This will help them increase their customer base.


List of companies with HQ



  • Medtronic (Ireland)

  • Boston Scientific (US)

  • Terumo Medical Corporation (US)

  • Teleflex Inc. (US)

  • Merit Medical Systems, Inc. (US)

  • Guerbet (France)

  • Cook Medical (US)

  • Acandis GmbH (Germany)

  • Acrostak (Switzerland)

  • Stryker Corporation (US)

  • Asahi Intecc (Japan)

  • Lepu Medical Technology Company (China)

  • Cerus Endovascular Ltd (US)


Recent Developments



  • In March 2021, Boston Scientific (US) acquired the global surgical business of Lumenis (Israel), a privately-held company that develops and commercializes energy-based medical solutions

  • In May 2018, Guerbet (France)launched two new microcatheters,SeQure and DraKonfor use in embolization procedures


Report Overview



  • The study covers the existing short-term and long-term market effect, as well as helping decision-makers to draught short-term and long-term plans for businesses by region. The report that covers major regions in North America, Europe, Asia-Pacific, and Rest of the World. It analyzes market drivers, restraints, opportunities, challenges, Porter’s five forces, Value Chain, and impact of COVID-19 on the market.


Scope of the Report



  • The scope of the microcatheters market study includes market size analysis and a detailed analysis of the manufacturer’s products and strategies. The market has been segmented based on design, product, application, end user, and region.


Microcatheters Market, By Design



  • Single Lumen

  • Double Lumen


Microcatheters Market, By Product



  • Aspiration Microcatheter

  • Delivery Microcatheter

  • Diagnostic Microcatheter

  • Steerable Microcatheter


Microcatheters Market, By Application



  • Cardiovascular

  • Neurovascular

  • Peripheral Vascular

  • Oncology

  • Urology


Microcatheters Market, By End User



  • Hospitals

  • Ambulatory Surgical Centers

  • Specialized Clinics


Microcatheters Market, by Region



  • North America


    • US

    • Canada


  • Europe


    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe


  • Asia-Pacific


    • China


      • Japan

      • India

      • Australia

      • South Korea

      • Rest of Asia-Pacific



  • Rest of the World


    • Middle East

    • Africa

    • Latin America



 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027:~USD 9,500 Million
  CAGR   ~4.1%
  Base Year   2020
  Forecast Period   2021-2027
  Historical Data   2017 & 2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Design, Product, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic (Ireland), Boston Scientific (US), Terumo Medical Corporation (US), Teleflex Inc. (US) Merit Medical Systems, Inc. (US), Guerbet (France), Cook Medical (US), Acandis GmbH (Germany), Acrostak (Switzerland) Stryker Corporation (US), Asahi Intecc (Japan), Lepu Medical Technology Company (China), Cerus Endovascular Ltd (US)
  Key Market Opportunities   • Technological advancements in the medical science • Increasing government funding for strengthening healthcare infrastructure
  Key Market Drivers   • Rise in the prevalence of chronic diseases such as neurovascular and cardiovascular disorders • Increasing adoption of minimally invasive surgery


Speak to Analyst Ask for Customization


This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.